Amarin Corp Plcuk (AMRN) Non Operating Income (2010 - 2026)

Amarin Corp Plcuk (AMRN) reported Non Operating Income of $188000.0 for Q1 2026, down 25.69% year-over-year from $253000.0 in Q1 2025, and down 93.53% quarter-over-quarter from $2.9 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Non Operating Income (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 17 years of Non Operating Income data on file, last reported at $188000.0 in Q1 2026.

  • Non Operating Income for Q1 2026 came in at $188000.0, down 25.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.2 million (up 3668.89% YoY), and the FY2025 annual result was $3.3 million, up 172.77% from the prior year.
  • Non Operating Income fell to $188000.0 in Q1 2026 per AMRN's latest filing, from $2.9 million in the prior quarter.
  • Over five years, Non Operating Income peaked at $5.0 million in Q4 2023 and troughed at -$2.3 million in Q2 2022.
  • A 5-year average of $704058.8 and a median of $253000.0 in 2025 frame the typical range for Non Operating Income.
  • On a YoY basis, Non Operating Income climbed as much as 1320.45% in 2022 and fell as far as 1080.63% in 2022.
  • A 5-year view of Non Operating Income shows it stood at $1.2 million in 2022, then soared by 296.0% to $5.0 million in 2023, then tumbled by 115.21% to -$753000.0 in 2024, then surged by 485.66% to $2.9 million in 2025, then tumbled by 93.53% to $188000.0 in 2026.
  • Business Quant data shows AMRN's Non Operating Income at $188000.0 in Q1 2026, $2.9 million in Q4 2025, and $205000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 195.49 Mn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn -65.00 Mn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn -294.00 Mn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn -2.31 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn -138.00 Mn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 75.00 Mn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 235.00 Mn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn -861.00 Mn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn -32.00 Mn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn 188,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 188,000.00
Dec 31, 2025 2.90 Mn
Sep 30, 2025 205,000.00
Jun 30, 2025 -85,000.00
Mar 31, 2025 253,000.00
Dec 31, 2024 -753,000.00
Sep 30, 2024 265,000.00
Jun 30, 2024 145,000.00
Mar 31, 2024 1.55 Mn
Dec 31, 2023 4.95 Mn
Sep 30, 2023 -575,000.00
Jun 30, 2023 3.04 Mn
Mar 31, 2023 624,000.00
Dec 31, 2022 1.25 Mn
Sep 30, 2022 511,000.00
Jun 30, 2022 -2.26 Mn
Mar 31, 2022 -246,000.00
Dec 31, 2021 88,000.00
Sep 30, 2021 -57,000.00
Jun 30, 2021 -191,000.00